即时生物过程拉曼分析仪市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Real-Time Bioprocess Raman Analyzer Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月21日 | 出版商:

Global Market Insights Inc. | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球即时生物过程拉曼分析仪市场价值为 4.076 亿美元，预计 2024 年至 2032 年将以 7.4% 的年复合成长率(CAGR) 增长。成长的市场需求生物製药的使用以及对生物过程即时监测的需求不断增长。市场依产品类型分为拉曼分析仪、拉曼探头和软体解决方案。 2023 年，拉曼分析仪是领先细分市场，营收为 1.663 亿美元。这些分析仪对于生物加工中的即时监测至关重要，并配备了可以准确检测和测量分子成分的光谱工具。

与探针和软体等补充产品相比，它们在准确性至关重要的生物製药製造中具有重要意义，使其成为市场上最重要的部分。在应用方面，即时生物过程拉曼分析仪市场分为生物过程分析和实验室到过程分析。 2023年，生物过程分析领域占据了大部分市场份额，占68.9%。拉曼分析仪提供即时资料的能力使製造商能够监测和控制基本参数，例如细胞密度、营养水平和产品品质。

这种能力可确保生物製品生产遵守监管标准和效率目标。随着生物製药复杂性的增加，特别是随着细胞和基因疗法等技术的进步，生物加工中对精确即时分析的需求变得更加重要。北美在 2023 年引领全球市场，营收为 1.524 亿美元，预计到 2032 年将达到 2.776 亿美元。品质的製造流程并遵守严格的法规。美国食品药物管理局 (FDA) 特别注重透过製程分析技术 (PAT) 框架来提高製程效率和产品品质。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	4.076 亿美元
预测值	7.671 亿美元
复合年增长率	7.4%

随着公司寻求优化其关键的生物製药工艺，这种监管环境刺激了对即时生物工艺分析仪（包括拉曼系统）的需求。

产业生态系统分析
产业影响力
- 成长动力
  - 越来越多采用生物製药
  - 需要即时过程监控
  - 拉曼光谱技术的进步
  - 对自动化和工业的日益关注
- 产业陷阱与挑战
  - 初始投资和营运成本高
成长潜力分析
监管环境
- 我们
- 欧洲
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
拉曼分析仪
- 桌上型拉曼分析仪
- 便携式拉曼分析仪
- 线上拉曼分析仪
- 线上拉曼分析仪
拉曼探头
软体

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
生物过程分析
实验室到过程分析

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
生物製药公司
合约製造组织
研究机构
其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第 9 章：公司简介

Agilent Technologies
B&W Tek
Bruker Corporation
Endress+Hauser Group
Horiba Group
Indatech - Chauvin Arnoux Group
MarqMetrix
Merck
Metrohm
METTLER TOLEDO
Real Time analyzers
Renishaw
Sartorius
Thermo Fisher Scientific
Wasatch Photonics

简介目录

Product Code: 11927

The Global Real-Time Bioprocess Raman Analyzer Market was valued at USD 407.6 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2032. This growth is fueled by several factors, including the increasing use of biopharmaceuticals and the rising need for real-time monitoring of bioprocesses. The market is segmented by product type into Raman analyzers, Raman probes, and software solutions. In 2023, Raman analyzers were the leading segment, generating revenues of USD 166.3 million. These analyzers are crucial for real-time monitoring in bioprocessing, equipped with spectroscopy tools that can accurately detect and measure molecular compositions.

Their significance in biopharmaceutical manufacturing, where accuracy is vital, makes them the most substantial segment in the market compared to complementary products such as probes and software. Regarding applications, the real-time bioprocess Raman analyzer market is categorized into bioprocess analysis and lab-to-process analysis. The bioprocess analysis segment held the majority of market share in 2023, accounting for 68.9%. The ability of Raman analyzers to deliver real-time data enables manufacturers to monitor and control essential parameters, such as cell density, nutrient levels, and product quality.

This capability ensures that biologics production adheres to regulatory standards and efficiency objectives. As the complexity of biopharmaceuticals increases-particularly with advancements like cell and gene therapies-the demand for precise real-time analysis in bioprocessing becomes even more critical. North America led the global market in 2023, with revenues of USD 152.4 million, and is expected to reach USD 277.6 million by 2032. This region is home to numerous prominent biopharmaceutical companies that heavily rely on real-time monitoring technologies, including Raman analyzers, to maintain high-quality manufacturing processes and comply with stringent regulations. The U.S. Food and Drug Administration (FDA) is particularly focused on enhancing process efficiency and product quality through the Process Analytical Technology (PAT) framework.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$407.6 Million
Forecast Value	$767.1 Million
CAGR	7.4%

This regulatory environment is stimulating the demand for real-time bioprocess analyzers, including Raman systems, as companies seek to optimize their critical biopharmaceutical processes.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing adoption of biopharmaceuticals
  - 3.2.1.2 Need for real-time process monitoring
  - 3.2.1.3 Advancements in Raman spectroscopy technology
  - 3.2.1.4 Rising focus on automation and industry
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High initial investment and operational costs
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
3.5 Technology landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Raman analyzers
- 5.2.1 Benchtop raman analyzers
- 5.2.2 Portable raman analyzers
- 5.2.3 On-line raman analyzers
- 5.2.4 In-line raman analyzers
5.3 Raman probes
5.4 Software

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Bioprocess analysis
6.3 Lab to process analysis

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Biopharmaceutical companies
7.3 Contract manufacturing organizations
7.4 Research organizations
7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE